Isolated hepatic perfusion for the treatment of patients with advanced liver metastases from pancreatic and gastrointestinal neuroendocrine neoplasms
- 31 December 2004
- Vol. 136 (6) , 1176-1182
- https://doi.org/10.1016/j.surg.2004.06.044
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Management of neuroendocrine liver metastasesThe American Journal of Surgery, 2004
- Technique and Results of Hyperthermic Isolated Hepatic Perfusion with Tumor Necrosis Factor and Melphalan for The Treatment of Unresectable Hepatic MalignanciesJournal of the American College of Surgeons, 2000
- Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study.Journal of Clinical Oncology, 1996
- Interaction of hyperthermia and chemotherapy agents; cell lethality and oncogenic potentialInternational Journal of Hyperthermia, 1994
- Synergistic effects of intratumor administration of cis‐diamminedichloroplatinum(II) combined with local hyperthermia in melanoma bearing miceJournal of Surgical Oncology, 1992
- Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell CarcinomaNew England Journal of Medicine, 1992
- Response of two mouse tumours to hyperthermia with CCNU or melphalanBritish Journal of Cancer, 1982